HomeEGRX • OTCMKTS
add
Eagle Pharmaceuticals Inc
Previous close
$0.70
Day range
$0.70 - $0.70
Year range
$0.010 - $3.87
Market cap
9.09M USD
Avg Volume
3.19K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 316.61M | 84.56% |
Operating expense | 121.21M | -4.25% |
Net income | 35.64M | 513.14% |
Net profit margin | 11.26 | 323.86% |
Earnings per share | 7.79 | 200.77% |
EBITDA | 112.48M | 1,622.84% |
Effective tax rate | 41.98% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 55.32M | -43.35% |
Total assets | 406.16M | 60.07% |
Total liabilities | 172.60M | 123.35% |
Total equity | 233.56M | — |
Shares outstanding | 13.08M | — |
Price to book | 0.04 | — |
Return on assets | 19.03% | — |
Return on capital | 24.99% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | 35.64M | 513.14% |
Cash from operations | 50.70M | 79.67% |
Cash from investing | -86.83M | -1,531.22% |
Cash from financing | -6.21M | 78.13% |
Net change in cash | -42.34M | -670.34% |
Free cash flow | 87.63M | 176.60% |
About
Founded
2007
Headquarters
Website
Employees
134
